SASKATCHEWAN EXPANDS COVERAGE FOR CYSTIC FIBROSIS MEDICATION
Saskatchewan is expanding coverage for Trikafta, a cystic fibrosis (CF) medication. Starting August 1, Trikafta will be available to CF patients ages six and older who meet the medical criteria.
"We are pleased to be able to expand coverage for this treatment for Saskatchewan children with cystic fibrosis," Health Minister Paul Merriman said. "We know that Trikafta has been shown to improve the quality of life for patients, and this expanded coverage will help children with CF and their families for years to come."
Trikafta targets specific genetic mutations that cause CF; this mutation affects approximately 90 per cent of CF patients.
"Today's news will change the trajectory of the disease and the future for many children in Saskatchewan who live with cystic fibrosis," President and CEO of Cystic Fibrosis Canada, Kelly Grover said. "Saskatchewan was one of the first provinces to fund the drug for those 12 years of age and older last year, and today has continued to recognize Trikafta's extraordinary, transformative value, by expanding coverage of Trikafta to include children ages six to 11 years old. We celebrate this news alongside our CF community in Saskatchewan, which has worked tirelessly for this day."
Saskatchewan Expands Coverage for Cystic Fibrosis Medication | News and Media | Government of Saskatchewan
CARGILL BREAKS GROUND ON $350 MILLION STATE-OF-THE-ART CANOLA CRUSH FACILITY
Premier Scott Moe, "Cargill has broken ground on their new $350 million state-of-the-art canola crush facility!
This investment will enhance our agricultural sector profile by bringing jobs and increased value-added production, while bolstering Saskatchewan’s position of becoming a global canola crush powerhouse."
https://regina.ctvnews.ca/new-cargill-canola-processing-facility-breaks-ground-in-regina-1.5993811
